Cargando…
A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting
OBJECTIVE: We report a case in which transient cerebral vasospasm after carotid artery stenting (CAS) was effectively treated using arterial and intravenous infusion of fasudil hydrochloride, but cerebral hyperperfusion syndrome (CHS) developed during subsequent treatment. CASE PRESENTATION: The pat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Neuroendovascular Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370509/ https://www.ncbi.nlm.nih.gov/pubmed/37502349 http://dx.doi.org/10.5797/jnet.cr.2022-0065 |
_version_ | 1785077948392407040 |
---|---|
author | Yamashina, Motoshige Sato, Yohei Noda, Mariko Sasakawa, Mayu Thamamongood, Thiparpa Hashizume, Akihiro Ogishima, Takahiro Tamaki, Masashi |
author_facet | Yamashina, Motoshige Sato, Yohei Noda, Mariko Sasakawa, Mayu Thamamongood, Thiparpa Hashizume, Akihiro Ogishima, Takahiro Tamaki, Masashi |
author_sort | Yamashina, Motoshige |
collection | PubMed |
description | OBJECTIVE: We report a case in which transient cerebral vasospasm after carotid artery stenting (CAS) was effectively treated using arterial and intravenous infusion of fasudil hydrochloride, but cerebral hyperperfusion syndrome (CHS) developed during subsequent treatment. CASE PRESENTATION: The patient was a 79-year-old man who underwent right CAS to treat symptomatic right carotid artery stenosis. After the procedure, the patient developed left paresis and unilateral spatial neglect. The following day, he developed diffuse cerebral vasospasm in the right middle cerebral artery that improved immediately upon arterial infusion of fasudil hydrochloride. Intravenous infusion of fasudil hydrochloride was then started, but CHS with epileptic seizures developed after 1 day of treatment. After 23 days of medical treatment, the condition of the patient improved to mild hemiparesis. CONCLUSION: The present case suggests that transient cerebral vasospasm after CAS may turn into CHS during treatment and that continuous monitoring for cerebral perfusion is important. |
format | Online Article Text |
id | pubmed-10370509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Japanese Society for Neuroendovascular Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-103705092023-07-27 A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting Yamashina, Motoshige Sato, Yohei Noda, Mariko Sasakawa, Mayu Thamamongood, Thiparpa Hashizume, Akihiro Ogishima, Takahiro Tamaki, Masashi J Neuroendovasc Ther Case Report OBJECTIVE: We report a case in which transient cerebral vasospasm after carotid artery stenting (CAS) was effectively treated using arterial and intravenous infusion of fasudil hydrochloride, but cerebral hyperperfusion syndrome (CHS) developed during subsequent treatment. CASE PRESENTATION: The patient was a 79-year-old man who underwent right CAS to treat symptomatic right carotid artery stenosis. After the procedure, the patient developed left paresis and unilateral spatial neglect. The following day, he developed diffuse cerebral vasospasm in the right middle cerebral artery that improved immediately upon arterial infusion of fasudil hydrochloride. Intravenous infusion of fasudil hydrochloride was then started, but CHS with epileptic seizures developed after 1 day of treatment. After 23 days of medical treatment, the condition of the patient improved to mild hemiparesis. CONCLUSION: The present case suggests that transient cerebral vasospasm after CAS may turn into CHS during treatment and that continuous monitoring for cerebral perfusion is important. The Japanese Society for Neuroendovascular Therapy 2023-01-14 2023 /pmc/articles/PMC10370509/ /pubmed/37502349 http://dx.doi.org/10.5797/jnet.cr.2022-0065 Text en ©2023 The Japanese Society for Neuroendovascular Therapy https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Case Report Yamashina, Motoshige Sato, Yohei Noda, Mariko Sasakawa, Mayu Thamamongood, Thiparpa Hashizume, Akihiro Ogishima, Takahiro Tamaki, Masashi A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting |
title | A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting |
title_full | A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting |
title_fullStr | A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting |
title_full_unstemmed | A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting |
title_short | A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting |
title_sort | case of cerebral hyperperfusion syndrome during treatment of transient cerebral vasospasm following carotid artery stenting |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370509/ https://www.ncbi.nlm.nih.gov/pubmed/37502349 http://dx.doi.org/10.5797/jnet.cr.2022-0065 |
work_keys_str_mv | AT yamashinamotoshige acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT satoyohei acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT nodamariko acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT sasakawamayu acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT thamamongoodthiparpa acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT hashizumeakihiro acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT ogishimatakahiro acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT tamakimasashi acaseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT yamashinamotoshige caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT satoyohei caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT nodamariko caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT sasakawamayu caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT thamamongoodthiparpa caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT hashizumeakihiro caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT ogishimatakahiro caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting AT tamakimasashi caseofcerebralhyperperfusionsyndromeduringtreatmentoftransientcerebralvasospasmfollowingcarotidarterystenting |